Life Sciences

Top Projects

 
Reasons to invest:

• Extensive network of life-science clusters and professional services
• World-class academic and institutional framework with significant achievements in basic and applied research
• Highly skilled graduates and laboratory workforce at reasonable cost
• Close links between industry, universities and the public healthcare system
• Regulatory and patent environment harmonious with the EU
• One of the largest and most well-developed drug markets in the CEE region
• Strong presence of large international pharmaceutical companies
• Significant cost advantages and potential to establish a gateway to growing pharmaceutical markets in the region

 The Czech Republic is a great place for contract R&D and manufacturing with a relatively non-restrictive genetic-engineering R&D climate, good patent protection and adoption of GMP, GLP and GCP standards.

 Czech companies and research institutions specialize in the following:

•  Monoclonal and polyclonal antibodies
• Antibody-based diagnostic kits
• Immunodiagnostic reagents
• Plant genomics
• Immunoanalytical tools
• ELISA diagnostic kits
• Bioinformatics
• Recombinant proteins
• Environmental-protection services

The Czech Republic is home to a number of noteworthy research institutes and universities that have achieved state-of-the-art results in the areas of immunology, rheumatology and pharmaceutical chemistry and have mastered high-quality research in neurosciences, oncology, diabetes and metabolic diseases. Based on the Government Decree of 2005, the country set molecular genetics and biotechnologies among the priority areas in the long-term, fundamental direction of research.